Rubio

Laboratorios Rubio is an established Spanish pharmaceutical company specializing in the development, manufacturing, and commercialization of medicines for niche therapeutic areas. Founded in 1968, the company has built a strong reputation in nephrology, urology, cardiovascular health, and rheumatology. Rubio is particularly well-known for its portfolio of ion-exchange resins used to treat electrolyte imbalances, such as hyperkalemia and hyperphosphatemia in patients with chronic kidney disease. The company operates internationally through a network of distributors and strategic partnerships, focusing on providing specialized treatments for chronic conditions. Its business model combines the commercialization of proprietary products with the licensing of innovative therapies from global partners.